BioXcel Therapeutics
BTAI
BTAI
44 hedge funds and large institutions have $29.4M invested in BioXcel Therapeutics in 2019 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 21 increasing their positions, 4 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
10% less capital invested
Capital invested by funds: $32.6M → $29.4M (-$3.16M)
Holders
44
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$1.48M | |
| 2 | +$1.48M | |
| 3 | +$1.43M | |
| 4 |
CH
CVI Holdings
Wilmington,
Delaware
|
+$1.12M |
| 5 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
+$898K |
Top Sellers
| 1 | -$175K | |
| 2 | -$16.8K | |
| 3 | -$9.16K | |
| 4 |
Barclays
London,
United Kingdom
|
-$6.43K |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$1K |